Protocol No
PULM-VERACYTE-ENVISIA-ILD
Staff Member
Jonathan Kurman
Phase
N/A
Summary
This project is being done to evaluate the impact of a genomic test, Envisia, in the diagnosis and management of your lung disease.
Objective
Prospective Observational Study of Clinical Utility of Envisia Genomic Classifier in Patients With Undiagnosed Interstitial Lung Disease
Study Sites
Froedtert Hospital
Status
OPEN TO ACCRUAL
Categories